SetPoint Medical Receives IDE Approval for U.S. Pivotal Trial to Study its Bioelectronic Platform in Rheumatoid Arthritis Patients

NEXT STORY
Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 11, 2020
PREV STORY
CorMedix Hosting KOL Call on Antimicrobial Resistance, Catheter-Related Bloodstream Infections (CRBSIs), and the Potential for Neutrolin®
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cempra to Present at Three Upcoming Investor Conferences

CHAPEL HILL, N.C., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...

author_avatar
NASDAQ Market News

Biopharmaceutical Processing Equipment and Consumables Market Worth 22.3 Billion USD by 2023

LONDON, July 23, 2018 (GLOBE NEWSWIRE) -- According to the latest publication from Meticulous ...

author_avatar
NASDAQ Market News

Checkpoint Therapeutics to Participate in June Investor Conferences

NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ:CKPT), a ...

author_avatar
NASDAQ Market News